Collegium Pharmaceutical, Inc

Ownership Transactions Reported by 16 Insiders

Symbol
COLL on Nasdaq
Industry
Pharmaceutical Preparations
Location
100 Technology Center Drive, Stoughton, MA

Insiders trading volume in the past year

Collegium Pharmaceutical, Inc executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Joseph Ciaffoni President and CEO, Director $15M Feb 12, 2024
Alison B. Fleming EVP & Chief Technical Officer $4.64M Aug 10, 2021
Colleen Tupper EVP & Chief Financial Officer $4.48M -$674K -13.1% May 28, 2024
Shirley R. Kuhlmann EVP and General Counsel $4.46M -$1.59M -26.2% Sep 5, 2024
Richard Malamut EVP and Chief Medical Officer $4.2M Feb 10, 2022
Vikram Karnani President and CEO, Director $3.88M Nov 12, 2024
Scott Dreyer EVP & Chief Commercial Officer $3.6M -$4.79M -57.1% May 23, 2024
John G. Freund Director $3.1M May 16, 2024
Gino Santini Director $2.44M May 16, 2024
Thomas B. Smith EVP and Chief Medical Officer $1.97M -$388K -16.4% Sep 13, 2024
John A. Fallon Director $1.77M May 16, 2024
Garen Bohlin Director $1.69M -$936K -35.6% May 14, 2024
Gwen A. Melincoff Director $1.69M May 16, 2024
Neil F. McFarlane Director $1.59M May 16, 2024
Rita J. Balice-Gordon Director $1.5M May 16, 2024
Michael Thomas Heffernan Director $1.47M May 16, 2024

Recent Insider Transactions by Companies or Individuals for Collegium Pharmaceutical, Inc

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.